Clinical trial
ST-segment Elevation Myocardial infArction Treated With a Polymer-free Sirolimus-based nanocarrieR Eluting Stent and a P2Y12 Inhibitor-based Aspirin-free Single Antiplatelet Strategy Versus Conventional Dual AntiPlatelet Therapy
NCT05785897 is registered in ClinicalTrials.gov with IGLESIAS Juan Fernando as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ST-segment Elevation Myocardial infArction Treated With a Polymer-free Sirolimus-based nanocarrieR Eluting Stent and a P2Y12 Inhibitor-based Aspirin-free Single Antiplatelet Strategy Versus Conventional Dual AntiPlatelet Therapy
- Lead sponsor
- IGLESIAS Juan Fernando
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 1, 2025
- Completion date
- March 1, 2028
- Enrollment
- 350 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.